(Q40001698)

16 September 2017

title

Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway (English)

1 reference

16 September 2017

1 reference

Jun-ichi Okano

1

1 reference

16 September 2017

Takakazu Nagahara

series ordinal

2

1 reference

16 September 2017

Kazuya Matsumoto

series ordinal

3

1 reference

16 September 2017

Yoshikazu Murawaki

series ordinal

4

1 reference

16 September 2017

language of work or name

1 reference

16 March 2008

1 reference

Basic and Clinical Pharmacology and Toxicology

16 September 2017

published in

1 reference

16 September 2017

volume

102

1 reference

16 September 2017

issue

6

1 reference

16 September 2017

page(s)

543-551

1 reference

Hepatocellular carcinoma development in cirrhosis

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

The enigmatic effects of caffeine in cell cycle and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Does coffee protect against hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Modulation of diethylnitrosamine carcinogenesis in rat liver and oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Cisplatin induces PKB/Akt activation and p38(MAPK) phosphorylation of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells: reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Caffeine induces apoptosis in human neuroblastoma cell line SK-N-MC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-7843.2008.00231.X

10.1111/J.1742-7843.2008.00231.X

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference